ABSTRACT
OBJECTIVES: We aimed to examine the potential protective effects of Iraqi H. tiliaceus L. chloroform leaves extract on DEN-induced HCC in male Wistar Albino rats. METHODS: Rats were assigned to four groups, six in each group. Group I: rats were administered a daily oral dose of 1â¯mL/kg/day of distilled water. Group II: rats were intraperitoneally injected with 70â¯mg/kg DEN once per week for 10 consecutive weeks. Group III: rats received 250â¯mg/kg of chloroform leaves extract. Groups IV: the rats were administered 500â¯mg/kg of chloroform leaves extract, along with their food, for five days per week over 20 weeks, with a subsequent dose of DEN once per week for 10 consecutive weeks. RESULTS: The results indicate that the extract demonstrated a significant reduction (p<0.05) in oxidative stress, pro-inflammatory mediators, and HCC parameters, the extract also had a beneficial effect on liver function tests, and there was a significant elevation (p<0.05) of antioxidant parameters in a dose-dependent manner. CONCLUSIONS: This study supports the protective properties of the chloroform extract of Iraqi H. tiliaceus L. leaves in HCC.
Subject(s)
Diethylnitrosamine , Hibiscus , Plant Extracts , Plant Leaves , Rats, Wistar , Animals , Plant Extracts/pharmacology , Male , Diethylnitrosamine/toxicity , Plant Leaves/chemistry , Hibiscus/chemistry , Rats , Antioxidants/pharmacology , Chloroform , Oxidative Stress/drug effects , Liver Neoplasms/chemically induced , Liver Neoplasms/drug therapy , Liver/drug effects , Liver/metabolism , Carcinoma, Hepatocellular/chemically induced , Carcinoma, Hepatocellular/drug therapy , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms, Experimental/prevention & control , PhytotherapyABSTRACT
Our previous study demonstrated that purple rice bran extract (PRBE) could inhibit diethylnitrosamine (DEN)-induced hepatocarcinogenesis. Protocatechuic acid (PCA) is the major phenolic acid contained in the PRBE. Therefore, this study aimed to determine whether PCA is an anticarcinogenic compound in purple rice extract. Rats were intraperitoneally injected with DEN to induce glutathione S-transferase placental form (GST-P)-positive foci. Rats were fed with PRBE at 500 mg kg-1 body weight or PCA at 4 mg kg-1 body weight for 5 and 15 weeks. PCA administration attenuated DEN-induced hepatic GST-P positive foci to a degree similar to PRBE. The molecular mechanisms of PCA in the initiation stage were correlated with reduced activity of cytochrome P450 reductase and induction of glutathione S-transferase. In addition, PCA also downregulated the expression of TNF-α and IL-1ß genes in rat liver. These genes are associated with the inhibition of inflammation. In the promotion stage, PCA suppressed cell proliferation correlated with the downregulation of Cyclin D1 expression. Moreover, it also induced apoptosis, indicated by increased expression of P53 and Bad genes, and decreased the expression of the anti-apoptotic Bcl-xl in DEN-initiated rats. These findings suggest that PCA is an active compound in the anticarcinogenic action of purple rice bran.
Subject(s)
Anticarcinogenic Agents , Liver Neoplasms, Experimental , Oryza , Animals , Anticarcinogenic Agents/pharmacology , Body Weight , Carcinogenesis/metabolism , Diethylnitrosamine/toxicity , Female , Glutathione Transferase/genetics , Glutathione Transferase/metabolism , Hydroxybenzoates , Liver/metabolism , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/prevention & control , Oryza/metabolism , Placenta/metabolism , Plant Extracts/pharmacology , Pregnancy , RatsABSTRACT
Hepatocellular carcinoma is a malignancy with poor clinical prognosis. Hepatic oval cells (HOCs) tend to differentiate into cancerous hepatocellular carcinoma cells (HCCs) in the tumor microenvironment. The purpose of the present study was to explore the role of kangxianruangan granule (KXRG)containing serum in inhibiting the differentiation of HOCs into HCCs via the Wnt1/ßcatenin signaling pathway. NmethylN'nitroNnitrosoguanidine (MNNG) was applied to induce the transformation of the rat HOC cell line WBF344 into HCCs. The overexpression plasmid, Wnt1up, was utilized to increase Wnt1 expression. Subsequently, high, medium and low concentrations of KXRG were applied to MNNGtreated WBF344 cells to assess the inhibitory effect of KXRG on cell differentiation. Flow cytometry was conducted to detect the cell cycle distribution, apoptotic rate and expression of cytokeratin19 (CK19) protein in cells. An immunofluorescence double staining protocol was used to detect the expression of Wnt1 and ßcatenin. ELISAs were performed to detect α fetoprotein in the cell supernatants. Reverse transcriptionquantitative PCR and western blotting were conducted to detect the mRNA and protein expression levels of Wnt1, ßcatenin, Cyclin D1, Cmyc, matrix metalloproteinase7 (MMP7), Axin2 and epithelial cell adhesion molecule (EpCAM) in cells. Compared with the normal group, the apoptotic rate, proportion of S phase cells, concentration of AFP in the cell supernatant, level of CK19 protein, and mRNA and protein expression levels of Wnt1, ßcatenin, Cyclin D1, Cmyc, MMP7, Axin2 and EpCAM were all significantly increased in the model group. Addition of KXRG significantly reduced the aforementioned indicators compared with the model group. Moreover, Wnt1 overexpression further increased the aforementioned indicators compared with the model group, whereas KXRG significantly inhibited these effects. The results indicated that KXRG inhibited the differentiation of HOCs into HCCs via the Wnt1/ßcatenin signaling pathway, which suggested the potential clinical application of KXRG for the prevention of hepatocellular carcinoma.
Subject(s)
Carcinoma, Hepatocellular/prevention & control , Cell Transformation, Neoplastic/drug effects , Drugs, Chinese Herbal/administration & dosage , Liver Neoplasms, Experimental/prevention & control , Wnt Signaling Pathway/drug effects , Animals , Carcinoma, Hepatocellular/chemically induced , Carcinoma, Hepatocellular/pathology , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Transformation, Neoplastic/chemically induced , Cell Transformation, Neoplastic/pathology , Disease Models, Animal , Humans , Liver/cytology , Liver/pathology , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/pathology , Male , Methylnitronitrosoguanidine/toxicity , Rats , Tumor Microenvironment/drug effectsABSTRACT
Hepatocellular carcinoma (HCC) has been identified as one of the most deadly malignancies with limited therapeutic efficacy worldwide. However, understanding the molecular mechanisms of crosstalk between signaling pathways in HCC and predicting cancer cell responses to targeted therapeutic interventions remain to be challenge. Thus, in this study, we aimed to evaluate the anticancerous efficacy of Silybum marianum total extract (STE), silymarin (Sm), and silibinin (Sb) against experimentally-induced HCC in rats. In vitro investigations were also performed and the anticancer effects against HCC cell lines (HepG2 and Huh7) were confirmed. Wistar rats were given diethylnitrosamine (DEN)/2-acetylaminofluorene (AAF)/carbon tetrachloride (CCl4) and were orally treated with STE (200 mg/kg body weight (bw)), Sm (150 mg/kg bw), and Sb (5 mg/kg bw) every other day from the 1st or 16th week to the 25th week of DEN/AAF/CCl4 injection. Treatment with STE, Sm, and Sb inhibited the growth of cancerous lesions in DEN/AAF/CCl4-treated rats. This inhibition was associated with inhibition of Ki-67 expression and repression of HGF/cMet, Wnt/ß-catenin, and PI3K/Akt/mTOR signaling pathways. STE, Sm, and Sb improved liver function biomarkers and tumor markers (AFP, CEA, and CA19.9) and increased total protein and albumin levels in serum. STE, Sm, and Sb treatment was also noted to reduce the hepatic production of lipid peroxides, increase hepatic glutathione content, and induce the activities of hepatic antioxidant enzymes in DEN/AAF/CCl4-treated rats. These results indicate that STE, Sm, and Sb exert anti-HCC effects through multiple pathways, including suppression of Ki-67 expression and HGF/cMet, Wnt/ß-catenin, and PI3K/Akt/mTOR pathways and enhancement of antioxidant defense mechanisms.
Subject(s)
Carcinoma, Hepatocellular/drug therapy , Liver Neoplasms, Experimental/prevention & control , Liver Neoplasms/drug therapy , Plant Extracts/pharmacology , Silybum marianum/chemistry , Animals , Antioxidants/metabolism , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Hep G2 Cells , Hepatocyte Growth Factor/metabolism , Humans , Liver Neoplasms/pathology , Male , Phosphatidylinositol 3-Kinase/metabolism , Plant Extracts/chemistry , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-met/metabolism , Rats , Rats, Wistar , Silybin/isolation & purification , Silybin/pharmacology , Silymarin/isolation & purification , Silymarin/pharmacology , Wnt Signaling Pathway/drug effectsABSTRACT
Royal jelly (RJ) and selenium (Se)-rich foods have well-known health benefits that are attributable to a broad range of pharmacological effects including antioxidant, anti-tumor, and immunoregulatory activities. However, the physiological effects of Se-rich RJ, which is produced by feeding Apis mellifera (Hymenoptera: Apidae) sodium selenite sucrose solution, are not well understood. The anti-hepatoma activity and mechanism of Se-rich RJ in H22 tumor-bearing mice were investigated in the current study. The findings showed that the content of organic and inorganic Se in Se-rich RJ was significantly higher than that in RJ. Furthermore, interleukin-2 (IL-2) levels and tumor necrosis factor-α (TNF-α) production in serum were increased and the malondialdehyde (MDA) content in liver was decreased in mice fed RJ and Se-rich RJ. 16SrRNA sequencing and serum untargeted metabolomics showed that RJ and Se-rich RJ could modulate the gut microbiota, and fisetin and L-glutathione oxidized were the main anti-tumor components in RJ and Se-rich RJ. Further analysis showed 11-deoxy prostaglandin F1ß was the specific anti-tumor metabolite in mice treated with Se-rich RJ compared with RJ. The results indicated that RJ and Se-rich RJ could inhibit the expression of PI3K and phosphorylation of AKT, induce cell apoptosis through the activation of caspase-9 and caspase-3, and regulate Bcl-2/Bax expression. RJ and Se-rich RJ also inhibited the expression of COX-2 and VEGF. To summarize, the findings clearly demonstrate that Se-rich RJ could inhibit tumor growth by inducing apoptosis and inhibiting angiogenesis as well as exhibit anti-tumor effects by improving immune function and antioxidant activities. The results indicated that Se-rich RJ could be a potential functional food for the management and prevention of cancer.
Subject(s)
Fatty Acids/administration & dosage , Fatty Acids/chemistry , Functional Food , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms, Experimental/prevention & control , Selenium/analysis , Animals , Antioxidants/metabolism , Cell Line, Tumor , Cytokines/blood , Female , Gastrointestinal Microbiome , Liver/metabolism , Liver/pathology , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/microbiology , Metabolome , Mice , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction , Transcriptome , Vascular Endothelial Growth Factor A/metabolismABSTRACT
AIM: Betel-nut, a popular masticatory among Southeast Asian populations is a class I carcinogen, previously associated with dyslipidemia and aberrant lipid metabolism, and is reported to be used more frequently by females, than males. This study investigates the potential of repurposing the anti-diabetic drug, vildagliptin, a dipeptidyl peptidase-4 inhibitor, for alleviating the oncogenic condition in female Swiss Albino mice administered an aqueous extract of betel-nut (AEBN) orally (2 mg ml-1) for 24 weeks. MAIN METHODS: Tissues were investigated by histopathological, immunohistochemical and apoptosis assays. Biochemical analyses of oxidative stress markers and lipid profile were performed using different tissues and sera. The expressions of different proteins involved in lipid metabolism and oncogenic pathways were evaluated by Western blotting. KEY FINDINGS: AEBN induced carcinogenesis primarily in the liver by significantly impairing AMPK signaling, inducing oxidative stress, activating Akt/mTOR signaling, increasing Ki-67 immunoreactivity and cyclin D1 expression, and significantly diminishing apoptosis. Co-administration of AEBN with vildagliptin (10 mg kg-1 body weight) for 8 weeks reduced liver dysplasia, and significantly decreased free palmitic acid, increased free oleic acid, normalized lipid profile, decreased oxidative stress, cyclin D1 expression, Ki-67 immunoreactivity, and Bcl2 expression, and increased the ratio of apoptotic/non-apoptotic cells. Mechanistically, vildagliptin elicited these physiological and molecular alterations by restoring normal AMPK signaling and reducing the cellular expressions of FASN and HMGCR, restoring AMPK-dependent phosphorylation of p53 at Ser-15 and reducing Akt/mTOR signaling. SIGNIFICANCE: These results indicate that vildagliptin may alleviate betel-nut induced carcinogenesis in the liver of female mice.
Subject(s)
Areca/toxicity , Dipeptidyl-Peptidase IV Inhibitors/pharmacology , Liver Neoplasms, Experimental/prevention & control , Oxidative Stress/drug effects , Plant Extracts/toxicity , Vildagliptin/pharmacology , Animals , Carcinogenesis , Dyslipidemias/chemically induced , Dyslipidemias/pathology , Dyslipidemias/prevention & control , Female , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/pathology , Mice , Signal TransductionABSTRACT
Hepatocellular carcinoma (HCC) is a highly morbid condition with lack of effective treatment options. HCC arises from chronically inflamed and damaged liver tissue; therefore, chemoprevention may be a useful strategy to reduce HCC incidence. Several reports suggest that epigallocatechin gallate (EGCG), extracted from green tea, can suppress liver inflammation and fibrosis in animal models, but its role in HCC chemoprevention is not well established. In this study, male Wistar rats were injected with diethylnitrosamine at 50 mg/kg for 18 weeks to induce cirrhosis and HCC, and EGCG was given in drinking water at a concentration of 0.02%. Clinically achievable dosing of EGCG was well-tolerated in diethylnitrosamine-injured rats and was associated with improved serum liver markers including alanine transaminase, aspartate transaminase, and total bilirubin, and reduced HCC tumor formation. Transcriptomic analysis of diethylnitrosamine-injured hepatic tissue was notable for increased expression of genes associated with the Hoshida high risk HCC gene signature, which was prevented with EGCG treatment. EGCG treatment also inhibited fibrosis progression, which was associated with inactivation of hepatic stellate cells and induction of the senescence-associated secretory phenotype. In conclusion, EGCG administered at clinically safe doses exhibited both chemopreventive and antifibrotic effects in a rat diethylnitrosamine liver injury model.
Subject(s)
Anticarcinogenic Agents/therapeutic use , Carcinoma, Hepatocellular/prevention & control , Catechin/analogs & derivatives , Cellular Senescence/drug effects , Hepatic Stellate Cells/drug effects , Liver Neoplasms, Experimental/prevention & control , Animals , Anticarcinogenic Agents/pharmacology , Biomarkers , Carcinoma, Hepatocellular/chemically induced , Catechin/pharmacology , Catechin/therapeutic use , Diethylnitrosamine , Hepatic Stellate Cells/metabolism , Liver Cirrhosis/chemically induced , Male , Phenotype , Precancerous Conditions/chemically induced , Rats , Tea/chemistry , TranscriptomeABSTRACT
Colorectal cancer (CRC) is known to be a life-threatening disease and commonly leads to metastasis in the liver. Fermented milk acts as an effective carrier for probiotic strains, whose consumption improves host health. Our previous study indicated that fermented milk that included a synbiotic combination of Lactobacillus gasseri 505 (505) and Cudrania tricuspidata leaf extract (CT) resulted in significantly greater anti-oxidative effects than fermented milk without CT. Therefore, we hypothesized that fermented milk containing CT and 505 (FCT) could result in hepatoprotective effects against CRC-induced liver metastasis. Liver inflammation and CRC were induced in male C57BL/6J mice, using azoxymethane/dextran sodium sulfate, and 505, CT, and FCT were administered to the 3 sample-treated 505, CT, and FCT groups, respectively, for 10 wk. The results showed that FCT treatment significantly reduced serum aspartate aminotransferase and alanine aminotransferase concentrations and elevated albumin concentrations. Moreover, the results of histological analysis showed that hepatic steatosis was notably reduced in the FCT group. Among the 3 sample-treated groups, the expression of mRNA associated with enzymes showing anti-oxidative activities, such as superoxide dismutase, catalase, and glutathione reductase, was the highest in the FCT-treated mice. In addition, FCT administration resulted in the greatest anti-inflammatory activity, as inflammatory marker levels (i.e., tumor necrosis factor-α, cyclooxygenase-2, myeloperoxidase, and nuclear factor kappa-light-chain enhancer of activated B cells) were significantly downregulated at the mRNA level and the expression of proteins associated with the nuclear factor kappa-light-chain enhancer of activated B cells and mitogen-activated protein kinase signaling pathways was suppressed by FCT. Therefore, this study demonstrated that fermented milk containing novel synbiotics has the potential to prevent hepatic toxicity induced because of CRC owing to its enhanced anti-oxidative and anti-inflammatory activities.
Subject(s)
Colorectal Neoplasms/drug therapy , Lactobacillus gasseri , Liver Neoplasms, Experimental/prevention & control , Liver Neoplasms, Experimental/secondary , Moraceae/chemistry , Plant Extracts/therapeutic use , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Colorectal Neoplasms/blood , Colorectal Neoplasms/chemically induced , Colorectal Neoplasms/pathology , Cultured Milk Products , Cyclooxygenase 2/metabolism , Dextran Sulfate , Fermentation , Lactobacillus gasseri/metabolism , Liver/metabolism , Male , Mice , Mice, Inbred C57BL , Milk , Probiotics , Protective Agents/therapeutic use , SynbioticsABSTRACT
BACKGROUND: Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death in the world. Choline deficiency has been well studied in the context of liver disease; however, less is known about the effects of choline supplementation in HCC. OBJECTIVE: The objective of this study was to test whether choline supplementation could influence the progression of HCC in a high-fat-diet (HFD)-driven mouse model. METHODS: Four-day-old male C57BL/6J mice were treated with the chemical carcinogen, 7,12-dimethylbenz[a]anthracene, and were randomly assigned at weaning to a cohort fed an HFD (60% kcal fat) or an HFD with supplemental choline (60% kcal fat, 1.2% choline; HFD+C) for 30 wk. Blood was isolated at 15 and 30 wk to measure immune cells by flow cytometry, and glucose-tolerance tests were performed 2 wk prior to killing. Overall tumor burden was quantified, hepatic lipids were measured enzymatically, and phosphatidylcholine species were measured by targeted MS methods. Gene expression and mitochondrial DNA were quantified by quantitative PCR. RESULTS: HFD+C mice exhibited a 50-90% increase in both circulating choline and betaine concentrations in the fed state (P ≤ 0.05). Choline supplementation resulted in a 55% decrease in total tumor numbers, a 67% decrease in tumor surface area, and a 50% decrease in hepatic steatosis after 30 wk of diet (P ≤ 0.05). Choline supplementation increased the abundance of mitochondria and the relative expression of ß-oxidation genes by 21% and â¼75-100%, respectively, in the liver. HFD+C attenuated circulating myeloid-derived suppressor cells at 15 wk of feeding (P ≤ 0.05). CONCLUSIONS: Choline supplementation attenuated HFD-induced HCC and hepatic steatosis in male C57BL/6J mice. These results suggest a therapeutic benefit of choline supplementation in blunting HCC progression.
Subject(s)
Choline/administration & dosage , Diet, High-Fat/adverse effects , Liver Neoplasms, Experimental/prevention & control , Liver Neoplasms/prevention & control , Animals , Betaine/blood , Choline/blood , DNA, Mitochondrial/analysis , Dietary Supplements , Fatty Liver/prevention & control , Gene Expression/drug effects , Lipid Metabolism/genetics , Liver/chemistry , Liver/pathology , Liver Neoplasms/etiology , Liver Neoplasms/pathology , Liver Neoplasms, Experimental/etiology , Liver Neoplasms, Experimental/pathology , Male , Mice , Mice, Inbred C57BL , Myeloid-Derived Suppressor Cells/pathology , Organ Size/drug effectsABSTRACT
Although hepatitis B and/or hepatitis C virus were recognized as major risk factor for the development of hepatocellular carcinoma (HCC), certain occupational, environmental, and lifestyle factors also play key roles in HCC tumorigenesis. Moreover, in molecular signaling route, extracellular signal-regulated kinase (ERK)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling was found to be overexpressed and linked to poor prognosis in HCC. Thus, to identify possible nature compound that can suppress ERK/NF-κB may be benefit to HCC patient. Magnolol, a natural compound derived from herbal plant Magnolia officinalis, has been recognized as a liver protection and antitumor reagent. However, whether magnolol-inhibited HCC progression correlates with disruption of ERK/NF-κB signaling is remained unclear. In this studies, we performed SK-Hep1/luc2 HCC bearing animal model to investigate the anticancer efficacy and mechanism of magnolol on tumor progression. Tumor size and tumor growth rate were dramatically suppressed after treatment of magnolol. In addition, expression of phospho-ERK (p-ERK), NF-κB p65 (Ser536), and tumor progression-associated proteins, such as matrix metallopeptidase 9 (MMP-9), vascular endothelial growth factor (VEGF), X-linked inhibitor of apoptosis protein (XIAP), and CyclinD1 were all significantly decreased by magnolol. Most important, major extrinsic and intrinsic apoptosis signaling factors, including active caspase-8 and caspase-9 were both enhanced by magnolol. This study indicated that apoptosis induction through extrinsic/intrinsic pathways and blockage of ERK/NF-κB activation were associated with magnolol-inhibited tumor progression in HCC in vivo.
Subject(s)
Apoptosis/drug effects , Biphenyl Compounds/pharmacology , Carcinoma, Hepatocellular/prevention & control , Extracellular Signal-Regulated MAP Kinases/metabolism , Lignans/pharmacology , Liver Neoplasms, Experimental/prevention & control , NF-kappa B/metabolism , Animals , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Disease Progression , Humans , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/pathology , Medicine, Chinese Traditional , Signal Transduction , Transcription Factor RelA/metabolismABSTRACT
Context: Chronic liver damage has serious medical consequences. Objective: To investigate the hepatoprotective effect of dry Zingiber officinale (ginger) and its essential (volatile) oil against diethylnitrosamine (DEN) toxicity in rats. Materials and methods: Phenols and flavonoids components were characterized in dry ginger using HPLC-UV instrument while ginger essential oil (E.O.) was investigated via GC-MS technique. Antioxidant activity was determined in vitro. In rat model, ginger was administrated for 2 months. Lipid profile, antioxidant biomarkers, liver functions and histopathology were assessed. Results: Chlorogenic acid (63.85 ppm) and hesperidin (156.91 ppm) are among the major phenolic and flavonoid constituents in dry ginger. Curcumene (15.21%) and linalool (13.47%) represent the main E.O. constituents. In rats treated with ginger E.O., a significant elevation in serum HDL (31.14%) was accompanied by a decrease in LDL (55.14%). A significant decrease in serum ALT and ALP was reported (56.85% and 53.84%, respectively). Serum GSH-Px activity has significantly increased 75.06%. Meanwhile, E.O. showed anticancer potential against HepG2 cell line (IC50 = 40 µg/mL). Liver histopathological examinations confirmed the protective effect against abnormalities. Conclusion: Ginger was able to reduce the severity of DEN-cytotoxicity in rats, which suggests a novel antioxidant role originating from this medicinal plant.
Subject(s)
Cytotoxins/toxicity , Diethylnitrosamine/toxicity , Liver Neoplasms, Experimental , Plant Extracts/pharmacology , Plant Oils/pharmacology , Zingiber officinale/chemistry , Animals , Antioxidants/pharmacology , Biomarkers/blood , Carcinoma, Hepatocellular/diet therapy , Carcinoma, Hepatocellular/prevention & control , Cell Line, Tumor , Herb-Drug Interactions , Humans , Liver Function Tests , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/diet therapy , Liver Neoplasms, Experimental/physiopathology , Liver Neoplasms, Experimental/prevention & control , Phytochemicals/pharmacology , RatsABSTRACT
Echinacoside (ECH) is a phenylethanoid glycoside extracted from a Chinese herbal medicine, Cistanches salsa. ECH possesses many biological properties, including anti-inflammation, neural protection, liver protection, and antitumor. In the current study, we aimed to explore the effects of ECH on hepatocellular carcinoma (HCC) and the underlying mechanisms. The results showed that ECH could attenuate diethylnitrosamine (DEN)-induced HCC in mice, and exerted antiproliferative and proapoptotic functions on HepG2 HCC cell line. ECH exposure in HepG2 cells dose-dependently reduced the phosphorylation of AKT (p-AKT) and enhanced the expression of p21 (a cell cycle inhibitor) and Bax (a proapoptotic protein). Furthermore, ECH significantly suppressed insulin-like growth factor-1-induced p-AKT and cell proliferation. These data indicated that phosphoinositide 3-kinase (PI3K)/AKT signaling was involved in the anti-HCC activity of ECH. Gene set enrichment analysis results revealed a positive correlation between the PI3K pathway and triggering receptors expressed on myeloid cells 2 (TREM2) expression in HCC tissues. ECH exposure significantly decreased TREM2 protein levels in HepG2 cells and DEN-induced HCC. Furthermore, ECH-mediated proliferation inhibition and AKT signaling inactivation were notably attenuated by TREM2 overexpression. In conclusion, ECH exerted its antitumor activity via decreasing TREM2 expression and PI3K/AKT signaling.
Subject(s)
Anticarcinogenic Agents/pharmacology , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Carcinoma, Hepatocellular/prevention & control , Cell Proliferation/drug effects , Glycosides/pharmacology , Liver Neoplasms, Experimental/prevention & control , Animals , Carcinoma, Hepatocellular/chemically induced , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Diethylnitrosamine , Hep G2 Cells , Humans , Liver Neoplasms, Experimental/chemically induced , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/pathology , Male , Membrane Glycoproteins/metabolism , Mice, Inbred C57BL , Phosphatidylinositol 3-Kinase/metabolism , Phosphorylation , Proto-Oncogene Proteins c-akt/metabolism , Receptors, Immunologic/metabolism , Signal TransductionABSTRACT
Both incidence and death rate due to liver cancer have increased in the United States. Higher consumption of lycopene-rich tomato and tomato products is associated with a decreased risk of cancers. ß-Carotene-15, 15'-oxygenase (BCO1), and ß-carotene-9', 10'-oxygenase (BCO2) cleave lycopene to produce bioactive apo-lycopenoids. Although BCO1/BCO2 polymorphisms affect human and animal lycopene levels, whether dietary tomato consumption can inhibit high-fat diet (HFD)-promoted hepatocellular carcinoma (HCC) development and affect gut microbiota in the absence of BCO1/BCO2 is unclear. BCO1/BCO2 double knockout mice were initiated with a hepatic carcinogen (diethylnitrosamine) at 2 weeks of age. At 6 weeks of age, the mice were randomly assigned to an HFD (60% of energy as fat) with or without tomato powder (TP) feeding for 24 weeks. Results showed that TP feeding significantly decreased HCC development (67%, 83%, and 95% reduction in incidence, multiplicity, and tumor volume, respectively, P < 0.05). Protective effects of TP feeding were associated with (1) decreased hepatic inflammatory foci development and mRNA expression of proinflammatory biomarkers (IL1ß, IL6, IL12α, monocyte chemoattractant protein-1, and inducible NO synthase); (2) increased mRNA expression of deacetylase sirtuin 1 and nicotinamide phosphoribosyltransferase involving NAD+ production; and (3) increased hepatic circadian clock genes (circadian locomotor output cycles kaput, period 2, and cryptochrome-2, Wee1). Furthermore, TP feeding increased gut microbial richness and diversity, and significantly decreased the relative abundance of the genus Clostridium and Mucispirillum, respectively. The present study demonstrates that dietary tomato feeding independent of carotenoid cleavage enzymes prevents HFD-induced inflammation with potential modulating gut microbiota and inhibits HFD-promoted HCC development.
Subject(s)
Carcinoma, Hepatocellular/prevention & control , Dietary Supplements , Liver Neoplasms, Experimental/prevention & control , Liver Neoplasms/prevention & control , Plant Extracts/administration & dosage , Solanum lycopersicum/chemistry , Animals , Carcinoma, Hepatocellular/etiology , Carotenoids/metabolism , Diet, High-Fat/adverse effects , Diethylnitrosamine/administration & dosage , Diethylnitrosamine/toxicity , Dioxygenases/genetics , Dioxygenases/metabolism , Gastrointestinal Microbiome/physiology , Humans , Liver Neoplasms/etiology , Liver Neoplasms, Experimental/etiology , Male , Mice , Mice, Knockout , Powders , beta-Carotene 15,15'-Monooxygenase/genetics , beta-Carotene 15,15'-Monooxygenase/metabolismABSTRACT
Obesity is associated with cancer risk and its link with liver cancer is particularly strong. Obesity causes non-alcoholic fatty liver disease (NAFLD) that could progress to hepatocellular carcinoma (HCC). Chronic inflammation likely plays a key role. We carried out a bioassay in the high-fat diet (HFD)-fed C57BL/6J mice to provide insight into the mechanisms of obesity-related HCC by studying γ-OHPdG, a mutagenic DNA adduct derived from lipid peroxidation. In an 80-week bioassay, mice received a low-fat diet (LFD), high-fat diet (HFD), and HFD with 2% Theaphenon E (TE) (HFD+TE). HFD mice developed a 42% incidence of HCC and LFD mice a 16%. Remarkably, TE, a standardized green tea extract formulation, completely blocked HCC in HFD mice with a 0% incidence. γ-OHPdG measured in the hepatic DNA of mice fed HFD and HFD+TE showed its levels increased during the early stages of NAFLD in HFD mice and the increases were significantly suppressed by TE, correlating with the tumor data. Whole-exome sequencing showed an increased mutation load in the liver tumors of HFD mice with G>A and G>T as the predominant mutations, consistent with the report that γ-OHPdG induces G>A and G>T. Furthermore, the mutation loads were significantly reduced in HFD+TE mice, particularly G>T, the most common mutation in human HCC. These results demonstrate in a relevant model of obesity-induced HCC that γ-OHPdG formation during fatty liver disease may be an initiating event for accumulated mutations that leads to HCC and this process can be effectively inhibited by TE. Cancer Prev Res; 11(10); 665-76. ©2018 AACR.
Subject(s)
Carcinoma, Hepatocellular/prevention & control , DNA Adducts/drug effects , Lipid Peroxidation/drug effects , Liver Neoplasms, Experimental/prevention & control , Plant Extracts/administration & dosage , Animals , Carcinogenesis/drug effects , Carcinogenesis/genetics , Carcinoma, Hepatocellular/epidemiology , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/pathology , Diet, High-Fat/adverse effects , Drug Screening Assays, Antitumor , Incidence , Liver/drug effects , Liver/pathology , Liver Neoplasms, Experimental/epidemiology , Liver Neoplasms, Experimental/etiology , Liver Neoplasms, Experimental/pathology , Male , Mice , Mice, Inbred C57BL , Mutation Rate , Obesity/complications , Obesity/etiology , Obesity/pathology , Plant Extracts/chemistry , Polyphenols/administration & dosage , Tea/chemistry , Exome SequencingABSTRACT
In this study Vernonia amygdalina. Delile stem and leaves were evaluated for anti-cancer and antibacterial actions against selected microorganisms. The crude plant extracts were extracted using methanol and fractionated into ethyl acetate, hexane, aqueous and crude extracts. Cancer inducing agent Carbon tetrachloride (CCl4) was introduced into Wistar mice and screened with crude extracts of Vernonia amygdalina. Delile to evaluate the anti-cancer properties of the extracts. The effect of CCl4 in mice was determined by isolating and quantifying damaged DNA fragments in liver and blood using DNA zol BD and diphenylamine (DPA). Results showed significant difference (p< 0.05) observed between the extracts and the controls. The observed changes obtained were concluded to be as a result of prophylactic effect of Vernonia amygdalina. Delile For the antibacterial studies, 20 mg/ml extracts fractions were tested against clinical isolates: Staphylococcus aureus, Bacillus subtilis, Salmonella typhi and Pseudomonas aeruginosa using agarwell diffusion technique. The extracts exhibited selective inhibitions against the isolates. The diameter of the zones of inhibitions observed were between: 0.0 - 35.0 mm, with ethyl acetate fraction given the highest inhibition. It was evident from this investigation that crude extracts of Vernonia amygdalina. Delile effectively reduced cancer damage caused by CCl4.
Subject(s)
Anti-Bacterial Agents/isolation & purification , DNA Damage , Liver Neoplasms, Experimental/prevention & control , Liver/drug effects , Plant Extracts/isolation & purification , Vernonia/chemistry , Animals , Anti-Bacterial Agents/pharmacology , Female , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Liver/pathology , Liver Neoplasms, Experimental/pathology , Male , Mice , Mice, Inbred Strains , Microbial Sensitivity Tests , Plant Extracts/therapeutic useABSTRACT
PURPOSE: Glycerol usage is increasing in food industry for human and animal nutrition. This study analyzed the impact of glycerol metabolism when orally supplemented during the early stage of rat liver carcinogenesis. METHODS: Wistar rats were subjected to a 2-phase model of hepatocarcinogenesis (initiated-promoted, IP group). IP animals also received glycerol by gavage (200 mg/kg body weight, IPGly group). RESULTS: Glycerol treatment reduced the volume of preneoplastic lesions by decreasing the proliferative status of liver foci, increasing the expression of p53 and p21 proteins and reducing the expression of cyclin D1 and cyclin-dependent kinase 1. Besides, apoptosis was enhanced in IPGly animals, given by an increment of Bax/Bcl-2 ratio, Bad and PUMA mitochondrial expression, a concomitant increase in cytochrome c release and caspase-3 activation. Furthermore, hepatic levels of glycerol phosphate and markers of oxidative stress were increased in IPGly rats. Oxidative stress intermediates act as intracellular messengers, inducing p53 activation and changes in JNK and Erk signaling pathways, with JNK activation and Erk inhibition. CONCLUSION: The present work provides novel data concerning the preventive actions of glycerol during the development of liver cancer and represents an economically feasible intervention to treat high-risk individuals.
Subject(s)
Anticarcinogenic Agents/therapeutic use , Apoptosis , Dietary Supplements , Glycerol/therapeutic use , Liver Neoplasms, Experimental/prevention & control , Oxidative Stress , Precancerous Conditions/prevention & control , Animals , Anticarcinogenic Agents/blood , Anticarcinogenic Agents/metabolism , Biomarkers/blood , Carcinogenesis , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Cell Proliferation , Gene Expression Regulation, Neoplastic , Glycerol/blood , Glycerol/metabolism , Lipid Peroxidation , Liver/enzymology , Liver/metabolism , Liver/pathology , Liver Neoplasms, Experimental/blood , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/pathology , MAP Kinase Signaling System , Male , Mitochondria, Liver/enzymology , Mitochondria, Liver/metabolism , Mitochondria, Liver/pathology , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Phosphorylation , Precancerous Conditions/blood , Precancerous Conditions/metabolism , Precancerous Conditions/pathology , Rats, Wistar , Tumor BurdenABSTRACT
Conflicting effects of antioxidant supplementation on cancer prevention or promotion is of great concern to healthy people and cancer patients. Despite recent studies about antioxidants accelerating the progression of lung cancer and melanoma, antioxidants may still play a role in cancer prevention. Both tumor and antioxidants types influence the actual efficacy. However, little is known about the impact of different types of antioxidants on primary hepatocellular carcinoma (HCC), including non-mitochondrial- and mitochondrial-targeted antioxidants. Utilizing mouse models of chemical hepatocarcinogenesis, we showed that administration of non-mitochondria-targeted antioxidants N-acetylcysteine (NAC) and the soluble vitamin E analog, Trolox, prevented tumorigenesis, whereas administration of mitochondria-targeted antioxidants SS-31 (the mitochondria-targeted peptide) and Mito-Q (a derivative of ubiquinone) facilitated tumorigenesis. RNA sequencing revealed that NAC and SS-31 caused very different changes in the oxidation-reduction state and DNA damage response. In diethylnitrosamine (DEN)-treated primary hepatocytes, NAC and Trolox alleviated DNA damage by activating ataxia-telangiectasia mutated (ATM)/ATM and Rad3-related (ATR) for DNA repair whereas SS-31 and Mito-Q aggravated damage by inactivating them. Interestingly, partial recovery of SS-31-scavengened mitochondrial reactive oxygen species (mtROS) could alleviate SS-31-aggravated DNA damage. Localization of ATM between mitochondria and nuclei was altered after NAC and SS-31 treatment. Furthermore, blockage of phospho-ATR (p-ATR) led to the recurrence of NAC-ameliorated DEN HCC. In contrast, reactivation of p-ATR blocked SS-31-promoted DEN HCC. Conclusion: These results demonstrate that the type of antioxidants plays a previously unappreciated role in hepatocarcinogenesis, and provide a mechanistic rationale for exploring the therapeutic use of antioxidants for liver cancer. (Hepatology 2018;67:623-635).
Subject(s)
Antioxidants/pharmacology , DNA Repair/drug effects , Liver Neoplasms, Experimental/chemically induced , Mitochondria/drug effects , Acetylcysteine/pharmacology , Animals , Ataxia Telangiectasia Mutated Proteins/physiology , Chromans/pharmacology , Diethylnitrosamine , Liver Neoplasms, Experimental/prevention & control , Male , Mice , Oligopeptides/pharmacology , Organophosphorus Compounds/pharmacology , Reactive Oxygen Species/metabolism , Ubiquinone/analogs & derivatives , Ubiquinone/pharmacologyABSTRACT
In recent years, naturally occurring phytochemicals with antioxidant capacity have generated surmount interest in their therapeutic usage against a wide range of pathological and toxicological conditions. The present study was designed to evaluate potential of ɣ-oryzanol (OZ), a bio-active natural antioxidant against hepatocellular carcinoma effect of the carcinogen N-nitrosodiethylamine in Balb/c mice. OZ inhibited the proliferation of Hep-3B cell line in concentration dependent manner. Administration of OZ to N-nitrosodiethylamine induced Balb/c mice for 16 and 32 weeks showed reduction in levels of liver injury markers, restored the levels of liver tumor markers, suppressed the hepatic nodular incidence and multiplicity, and favorably modulated the liver antioxidant status in a time dependent manner. Histologically, no obvious signs of neoplasia in the liver tissues were observed in OZ supplemented rats with N-nitrosodiethylamine induced liver tumerogenesis. OZ was found to be effective for reduction of N-nitrosodiethylamine induced hepatocellular carcinoma.
Subject(s)
Diethylnitrosamine/toxicity , Liver Neoplasms, Experimental/prevention & control , Phenylpropionates/administration & dosage , Animals , Biomarkers, Tumor/blood , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Humans , Liver Neoplasms, Experimental/blood , Liver Neoplasms, Experimental/chemically induced , Mice , Mice, Inbred BALB C , Phenylpropionates/pharmacology , Xenograft Model Antitumor AssaysABSTRACT
Hexachlorobezene (HCB), a fungicide widely distributed in the environment, promotes the development of hepatocellular preneoplastic lesions (PNL) and tumors in rodents. In contrast, vitamin D3 (VD3) supplementation presents a potential role for the prevention/treatment of chronic liver diseases. Thus, we investigated whether VD3 supplementation attenuates the early stage of HCB-promoted hepatocarcinogenesis. Female Balb/C mice were injected a single dose of diethylnitrosamine (DEN, 50 mg/kg) at postnatal day 15. From day 40 onwards, mice were fed with a standard diet containing 0.02% HCB alone or supplemented with VD3 (10,000 or 20,000 IU/Kg diet) for 20 weeks. Untreated mice were fed just standard diet. After this period, mice were euthanized and liver and serum samples were collected. Compared to the untreated group, DEN/HCB treatment decreased total hepatic glutathione levels and glutathione peroxidase (GSH-Px) activity while increased lipid peroxidation, p65 protein expression, cell proliferation/apoptosis and the PNL development. In contrast, dietary VD3 supplementation enhanced vitamin D receptor (VDR) protein expression, total glutathione levels and GSH-Px activity while diminished lipid hydroperoxide levels. Also, VD3 supplementation decreased p65 protein expression, hepatocyte proliferation, the size and the liver area occupied by PNL. Therefore, our findings indicate that VD3 supplementation attenuates the early stage of HCB-promoted hepatocarcinogenesis.
Subject(s)
Cholecalciferol/administration & dosage , Dietary Supplements/analysis , Fungicides, Industrial/toxicity , Hexachlorobenzene/toxicity , Liver Neoplasms, Experimental/prevention & control , Animals , Apoptosis/drug effects , Cell Proliferation/drug effects , Cholecalciferol/analysis , Female , Fungicides, Industrial/metabolism , Glutathione/metabolism , Hexachlorobenzene/metabolism , Humans , Liver/drug effects , Liver/metabolism , Liver Neoplasms, Experimental/etiology , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/pathology , Mice , Mice, Inbred BALB C , Oxidative Stress/drug effects , Receptors, Calcitriol/genetics , Receptors, Calcitriol/metabolismABSTRACT
CONTEXT: Hepatocellular carcinoma (HCC) is among the most well-known threatening tumours around the world, and the outlook remains bleak. Moringa oleifera Lam. (Moringaceae) exhibits antitumor, antioxidant and hepatoprotective properties. OBJECTIVES: To assess the chemo-prophylactic proficiency and other likely activities of Moringa oleifera leaf ethanol extract (MOLEE) against diethyl nitrosamine (DEN)-induced HCC. MATERIALS AND METHODS: Wistar rats were gastrogavaged with MOLEE (500 mg/kg) for one week and then gastrogavaged with MOLEE and DEN (10 mg/kg) for the following 16 weeks. The progressions of the histological components, serum biomarkers and oxidation of DNA of the liver tissues were resolved to assess the prophylactic impacts. The lipid oxidative biomarker, the cancer prevention agent status and apoptotic proteins were surveyed to assess the potential mechanisms. RESULTS: The MOLEE LD50 was estimated to be 5585 mg/kg. MOLEE (500 mg/kg) administration fundamentally repressed the expansion event of knobs and the normal knob number per knob-bearing livers prompted by DEN, enhanced hepatocellular appearance and altogether significantly decreased (p < 0.05) DEN-induced elevations in serum biochemical records and hepatic 8-hydroxy-2-deoxyguanosine (8-OHdG) levels by 29%. The robotic studies found that MOLEE disrupted the DEN-activated oxidative reactivity damage in rats by 46.8%. Curiously, the expression of Bcl-2, Bcl-xl and ß-arrestin-2 were fundamentally diminished (p < 0.05); however, the expression of Bax and caspase-3 were essentially (p < 0.05) upregulated. DISCUSSION AND CONCLUSIONS: The outcomes presume that MOLEE inspired critical defensive impacts against DEN-induced hepatocarcinogenesis that might be identified with the implementation of antioxidant activity and actuation of apoptosis.